Harm Reduction Cannot Mean “Give Me What I Want—or I’ll Do Something Worse”
Harm reduction is one of the most attractive phrases in modern public health. It suggests compassion over punishment, realism over moralizing, and concern for actual human beings rather than abstract rules.
At its best, harm reduction does exactly that. Providing naloxone to prevent overdose, offering sterile syringes to reduce infections, or helping someone transition from an unregulated drug supply to evidence-based treatment can save lives. These interventions recognize a basic medical truth: people do not become healthier because we shame them, abandon them, or insist that change must happen immediately.
But harm reduction can be distorted into something quite different: a demand that society preserve access to a harmful product because the consumer threatens to obtain something even worse if it is restricted.
The argument goes like this: “If you do not let me buy this vape, this drug, this high-potency product, or this risky substance legally, I will buy it illegally. Therefore, you must keep the legal version available.”
This is not harm reduction. It is hostage-taking.
The person making the threat may be sincere. They may be dependent, frightened, angry, or simply unwilling to give up a preferred product. Their concern about the illicit market may also be factually reasonable. Illegal products are often unregulated, adulterated, mislabeled, or more dangerous than legal alternatives.
Still, none of that means public policy must yield.
In 2019, as cases of vaping-associated lung injury emerged across the United States, Massachusetts temporarily removed vaping products from legal sale while officials tried to understand the threat. The move was controversial, in part because people argued that a ban would push consumers toward the illicit market. Yet the EVALI outbreak itself illustrated why that concern could not be the sole basis for policy: vitamin E acetate became strongly associated with the outbreak, particularly in THC-containing vaping products obtained from informal sources.[4][3]
At the time, uncertainty was the point. When a new and potentially fatal danger is emerging, regulators may reasonably decide that pausing access is safer than pretending they already know which products are safe.
The appropriate response to such a pause is not, “Then I will buy something more dangerous, so you must keep selling me the thing you are worried may harm me.” That statement describes a person’s intention. It does not establish an entitlement.
We would recognize this in many other areas of life. If a restaurant is temporarily closed because of a suspected foodborne outbreak, a customer cannot reasonably say, “Reopen immediately, or I will eat spoiled food from an unlicensed vendor.” If a physician stops prescribing an unsafe medication, a patient cannot compel the prescription by threatening to obtain counterfeit pills online.
The threat may increase the urgency of finding alternatives. It does not make the unsafe option medically appropriate.
This is where harm reduction must be disciplined by professional judgment. The goal is neither prohibition for its own sake nor naïve permissiveness. It is to reduce risk without allowing threatened self-harm to dictate the boundaries of care or regulation.
A better response to the person who says, “If you take away my legal vape, I will buy an illegal one,” is: “I understand the concern. Let’s address the dependence, symptoms, and needs that make this feel necessary. But I cannot conclude that a product should remain available merely because you promise to make a more dangerous choice without it.”
That answer is neither punitive nor dismissive. It accepts that the person may face real difficulty. It offers help. It avoids shame. But it also preserves an essential principle: individual choices have consequences, and public policy cannot be held hostage by the threat of worse choices.
Harm reduction works best when it expands options: treatment, counseling, nicotine replacement, regulated and evidence-based medications, accurate information, and support for behavior change. It fails when it narrows policy to one demand—continued access to a desired but harmful product.
Compassion is not the same as capitulation. Sometimes the most responsible public-health decision is to say: we will help you through this, but we will not keep a potentially dangerous product available simply because you threaten to seek out something worse.
References:
1. https://pmc.ncbi.nlm.nih.gov/articles/PMC7816198/
2. https://www.mass.gov/guides/2019-tobacco-control-law
3. https://archive.cdc.gov/www_cdc_gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html
4. https://www.cdc.gov/mmwr/volumes/69/wr/mm6903e2.htm
5. https://en.wikipedia.org/wiki/2019–2020_vaping_lung_illness_outbreak
6. https://www.sciencedirect.com/science/article/abs/pii/S0955395920303649
7. https://www.contemporarypediatrics.com/view/evali-cases-linked-illicit-thc-cartridges
8. https://onlinemha.bc.edu/who-regulates-vaping-in-massachusetts/
9. https://getpotency.com/what-you-need-to-know-about-vape-laws-in-massachusetts/
10. https://www.youtube.com/watch?v=ijvD-yrcYJ8
11. https://www.tobaccoinduceddiseases.org/Characterizing-and-assessing-compliance-of-online-vendors-to-nthe-state-of-Massachusetts,131199,0,2.html
12. https://pmc.ncbi.nlm.nih.gov/articles/PMC6881051/
13. https://www.npr.org/sections/health-shots/2019/12/20/790154919/cdc-confirms-a-thc-contaminant-vitamin-e-acetate-the-culprit-in-most-vaping-deat
14. https://www.lung.org/media/press-releases/vitamin-e-acetate-evali
https://www.bu.edu/articles/2019/massachusetts-ban-on-vaping-products/